-+ 0.00%
-+ 0.00%
-+ 0.00%

Intervacc Q3 Operating Loss Widens to SEK 27.18 Million

PUBT·11/12/2026 07:34:56
Listen to the news
Intervacc Q3 Operating Loss Widens to SEK 27.18 Million
  • Intervacc's third-quarter 2026 operating loss widened to SEK 27.18 million from SEK 14.98 million a year earlier.
  • Net sales fell to SEK 4.62 million from SEK 5.38 million, reflecting weaker European activity during distributor Dechra's reorganization.
  • The January-September operating loss widened to SEK 69.99 million from SEK 47.12 million a year earlier.
  • Over those nine months, Swedish Strangvac sales rose 54%; Scandinavian veterinary medicine sales increased 29%.
  • Monitoring of the first 100,000 Strangvac doses sold identified three confirmed strangles cases in fully vaccinated horses.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intervacc AB published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.